4//SEC Filing
GUSKY DAVID P 4
Accession 0001140361-18-012108
CIK 0001012477other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:42 PM ET
Size
10.6 KB
Accession
0001140361-18-012108
Insider Transaction Report
Form 4
GUSKY DAVID P
Controller & CAO
Transactions
- Award
Stock Option (right to buy)
2017-12-12$8.95/sh+12,600$112,770→ 12,600 totalExercise: $8.95Exp: 2027-12-12→ ADSs (12,600 underlying) - Award
ADSs
2017-12-12+2,700→ 4,700 total
Holdings
- 50,000
Stock Option (right to buy)
Exercise: $7.85Exp: 2026-03-02→ ADSs (50,000 underlying) - 14,000
Stock Option (right to buy)
Exercise: $10.40Exp: 2026-12-14→ ADSs (14,000 underlying)
Footnotes (5)
- [F1]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
- [F2]Includes (a) 2,000 restricted ADSs granted under the issuer's "Free Share" award program on 12/14/2016, all of which will be issued to the reporting person on the second anniversary of the grant date; and (b) 2,700 restricted shares granted under the issuer's Omnibus Incentive Compensation Plan on 12/12/2017, under which 1,800 ADSs will vest and be issued on the second anniversary of the grant date and the remaining 900 ADSs will vest and be issued on the third anniversary of the grant date (with vesting of these restricted shares subject to the reporting person remaining in continuous service until the applicable anniversary of the date of grant).
- [F3]Options become exercisable as to 12,500 ADSs on each of the first four anniversaries after the 03/02/2016 grant date.
- [F4]Options become exercisable as to 3,500 ADSs on each of the first four anniversaries after the 12/14/2016 grant date.
- [F5]Options become exercisable as to 3,150 ADSs on each of the first four anniversaries after the 12/12/2017 grant date.
Documents
Issuer
AVADEL PHARMACEUTICALS PLC
CIK 0001012477
Entity typeother
Related Parties
1- filerCIK 0001667465
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 6:42 PM ET
- Size
- 10.6 KB